61 filings
Page 2 of 4
8-K
x51ezimnm4
27 Nov 23
Other Events
8:28am
8-K
n4au6 o9qt6tdupag1
21 Nov 23
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
6:04pm
8-K
trnf8f7zyh80d nm
30 Oct 23
FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients
8:15am
8-K
953iu8 lckszm
3 Oct 23
Company to finalize labeling with FDA Approvable Letter expected within a month
4:07pm
8-K
0ms6xe8sy
26 Sep 23
Other Events
9:33am
8-K
u08ybo2
20 Sep 23
Amendments to Articles of Incorporation or Bylaws
5:16pm
8-K
74do 3ud4i
8 Sep 23
Submission of Matters to a Vote of Security Holders
2:30pm
8-K
q3u7g0g7h r5t
30 Aug 23
Entry into a Material Definitive Agreement
4:35pm
8-K
250spt5
24 Aug 23
Regulation FD Disclosure
5:15pm
8-K
afc q8ejphsab7
14 Aug 23
SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update
6:46pm
8-K
0fy0sa vsdse5f5785
7 Aug 23
Entry into a Material Definitive Agreement
8:23pm
8-K
ibq1 kf9m3ndobml835
2 Aug 23
Changes in Registrant's Certifying Accountant
4:19pm
8-K
jh1gvkjtgz7ji6qygh
30 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:06pm
8-K
ul6nnrfj4u qlqmtviyv
16 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
pd1 dg0n5yyzowu4vgm
9 Jun 23
Entry into a Material Definitive Agreement
4:01pm
8-K
qggs30d
16 May 23
SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update
4:06pm
8-K
2ejv 3octwdk
9 May 23
SeaStar Medical Provides Regulatory Update Related to its HDE Application for Pediatric Selective Cytopheretic Device
5:02pm
8-K
21ma0c2z3q3az7qvwkz
30 Mar 23
SeaStar Medical Reports 2022 Financial Results and Provides a Business Update
9:58pm
8-K
h28mdmm7ph5iel33i
16 Mar 23
SeaStar Medical Holding Corporation Closes Initial $3.3 Million Tranche of $9.8 Million Private Placement
8:30am
8-K
i2p1jttqhxcx0e
15 Feb 23
Regulation FD Disclosure
12:00am